A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 446 participants.
Also called NCT05301712
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 446 participants
- Registry
-
NCT05301712
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05301712. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2022-10-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke
- Condition
- Stroke, Acute
- Intervention (Drug)
- Naloxone hydrochloride 5.0mg/5ml
- Intervention (Drug)
- Sodium Chloride 45mg/5ml
- Lead sponsor
- Samjin Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct05301712- Content hash
0fe8d923dfa6a97db6e06d2e93d75951d381631e768626d06ad6a8245c3cfb2c